The University of Wisconsin-Madison has had a T32 program for "Physician Scientist Training in Cancer Medicine" since 1988. The purpose of this program has been to train physicians in laboratory-oriented research to prepare them for independent academic careers in cancer-focused medicine. This has been in response to a national problem of declining numbers of physician scientists entering research-related careers over the last three decades. The past success of our program can be judged by the numbers of our trainees who have continued in academic research-related careers. Over the 1993-2003 decade of funding, 19 of 26 (73%) trainees are in academic faculty positions. Since 2003, nearly all of our trainees continue in training for future academic careers. The current application requests support to continue this program, and describes our efforts to further improve on our past success with regards to training, monitoring outcomes, and our efforts to recruit trainees of diverse and underrepresented ethnic and cultural backgrounds.
Our specific aim i s to develop physicians as scientists with a strong foundation in basic and translational cancer research to help prepare them for careers in academic medicine.

Public Health Relevance

There is a national shortage of physician scientists. This grant trains physicians in cancer research from specialties such as medical oncology, hematology, gastroenterology, pediatric oncology, and radiation oncology to developing laboratory/translational academic careers. Thus, this training is highly relevant to the mission of the National Cancer Institute.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Murray, Sara E; Pathak, Priya R; Schaefer, Sarah C et al. (2014) Improvement of sleep disturbance and insomnia following parathyroidectomy for primary hyperparathyroidism. World J Surg 38:542-8
Schneider, David F; Nookala, Ratnam; Jaraczewski, Taylor J et al. (2014) Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism. Ann Surg Oncol 21:2303-9
Schneider, David F; Mazeh, Haggi; Oltmann, Sarah C et al. (2014) Novel thyroidectomy difficulty scale correlates with operative times. World J Surg 38:1984-9
Schneider, David F; Sonderman, Philip E; Jones, Michaela F et al. (2014) Failure of radioactive iodine in the treatment of hyperthyroidism. Ann Surg Oncol 21:4174-80
Paul Olson, Terrah J; Hadac, Jamie N; Sievers, Chelsie K et al. (2014) Dynamic tumor growth patterns in a novel murine model of colorectal cancer. Cancer Prev Res (Phila) 7:105-13
Deming, Dustin A; Maher, Molly E; Leystra, Alyssa A et al. (2014) Phospholipid ether analogs for the detection of colorectal tumors. PLoS One 9:e109668
Oltmann, Sarah C; Schneider, David F; Leverson, Glen et al. (2014) Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation. Ann Surg Oncol 21:1379-83
Deming, D A; Leystra, A A; Nettekoven, L et al. (2014) PIK3CA and APC mutations are synergistic in the development of intestinal cancers. Oncogene 33:2245-54
Deming, Dustin A; Ninan, Jacob; Bailey, Howard H et al. (2014) A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors. Invest New Drugs 32:323-9
Murray, Sara E; Lloyd, Ricardo V; Sippel, Rebecca S et al. (2014) Postoperative surveillance of small appendiceal carcinoid tumors. Am J Surg 207:342-5; discussion 345

Showing the most recent 10 out of 109 publications